CClinicalTrials.gg
CompletedNCT06630442Updated May 15, 2025

Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment

An interventional study of Educational Intervention and Questionnaire Administration in Hematopoietic and Lymphatic System Neoplasm and Malignant Solid Neoplasm, sponsored by Ohio State University Comprehensive Cancer Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-15.

Sponsored by Ohio State University Comprehensive Cancer Center · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Feb 2022, registered Oct 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This clinical trial evaluates the impact of a food safety educational training program on food safety knowledge and behaviors in cancer patients receiving treatment. Cancer treatments, such as chemotherapy, can put patients at risk for foodborne infections and despite this risk, it has been reported that patients do not receive any food safety counseling until they are already experiencing low white blood cell counts. A food safety educational training program may help cancer patients make better choices of low-risk foods and prepare foods safely.

Read the detailed description

PRIMARY OBJECTIVE:

I. Evaluate the efficacy of a food safety education intervention for cancer patients.

OUTLINE:

Patients attend a food safety educational training program over 50 minutes on study.

After completion of study intervention, patients are followed up at 5 weeks.

02

Conditions studied

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Browse trials for

03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 120 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Ohio State University Comprehensive Cancer Center is the lead sponsor of 369 studies on the registry; 81 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 19 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants must be at least 18 years of age
  • Able to fluently read and converse in English (though it does not have to be their first language)
  • All participants must be diagnosed with cancer, any stage, and be receiving some form of treatment at the aforementioned facilities
  • Informed consent must be obtained from each patient prior to participation in any aspect of the study

Exclusion criteria

Exclusion Criteria:

  • Patients who do not meet these criteria or are not willing or are unable to give informed consent, will be excluded from this study
  • Patients with prescribed dietary limitations or currently on neutropenic diet unrelated to this study will not be included
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Supportive care (food safety educational training)

    Patients attend a food safety educational training program over 50 minutes on study.

    Other: Educational Intervention · Other: Questionnaire Administration

Interventions

  • OtherEducational Intervention

    Attend a food safety educational training program

    Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

  • OtherQuestionnaire Administration

    Ancillary studies

06

What researchers measure

Primary outcomes

  1. Changes in food safety knowledge

    Pre and post responses will be determined using score calculation and compared using analysis of variance (ANOVA).

    Time frame: From baseline up to 5 weeks post intervention

  2. Changes in attitudes

    Pre and post responses will be determined using score calculation and compared using ANOVA.

    Time frame: From baseline up to 5 weeks post intervention

  3. Changes in risk perception

    Pre and post responses will be determined using score calculation and compared using ANOVA.

    Time frame: From baseline up to 5 weeks post intervention

  4. Changes in self-efficacy

    Pre and post responses will be determined using score calculation and compared using ANOVA.

    Time frame: From baseline up to 5 weeks post intervention

  5. Changes in behaviors

    Pre and post responses will be determined using score calculation and compared using ANOVA.

    Time frame: From baseline up to 5 weeks post intervention

  6. Changes in food acquisition practices

    Pre and post responses will be determined using score calculation and compared using ANOVA.

    Time frame: From baseline up to 5 weeks post intervention

  7. Changes in high-risk food consumption

    Pre and post responses will be determined using score calculation and compared using ANOVA.

    Time frame: From baseline up to 5 weeks post intervention

07

Study locations

1 site
  • Ohio State University Comprehensive Cancer Center
    Columbus, Ohio 43210, United States
08

References and documents

Related links

Study documents

  • Informed consent form · Jul 22, 2020

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06630442
Lead sponsor
Ohio State University Comprehensive Cancer Center
Responsible party
Sanja Ilic (Principal Investigator, Ohio State University Comprehensive Cancer Center) — Principal investigator
First posted
Oct 8, 2024
Start date
Feb 21, 2022
Primary completion
Nov 14, 2022
Completion
Nov 14, 2022
Last update
May 15, 2025

Study contacts

Sanja Ilic
principal investigator · Ohio State University Comprehensive Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion